At a glance
ClinicalIndex Comparison RecordN/ACompleted· 70 enrolled
Drug / intervention
Crosslinked hyaluronic acid dermal fillerdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Post-Market Study of JUVÉDERM VOLIFT™ With Lidocaine for the Correction of Nasolabial Folds
In Brief
A clinical study evaluating Crosslinked hyaluronic acid dermal filler for Moderate to Severe Nasolabial Folds. Completed, enrolled 70 participants across 3 sites in 2 countries.
Detailed Summary
A prospective, open-label, multi-center, observational, post-market study evaluating JUVÉDERM VOLIFT™ for the correction of moderate to severe nasolabial folds
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsModerate to Severe Nasolabial Folds
CountriesGermany, Netherlands
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2012
First PostedSep 2012
Primary CompletionMar 2014
TodayJul 2026
First PostedSep 7, 2012
Enrollment StartJun 1, 2012
Primary CompletionMar 6, 2014
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 13.8 years ago
Interventions
Crosslinked hyaluronic acid dermal fillerdevice
All treatment details are at the discretion of the Investigator and should be guided by the Directions for Use. Up to 3 treatments will be administered: Initial treatment, optional top-up treatment at Day 14 post-initial treatment, and optional repeat treatment at Month 12 post-initial treatment.